Kenneth DenBleyker

Statistics

Publications

Citations

398

H-Index

Active since

1991

Affiliations

Bristol-Myers Squibb (United States)(Current)

Kenneth DenBleyker is an author at Bristol-Myers Squibb (United States) specializing in antibiotic resistance, medicinal chemistry, and drug discovery.

Publications per year

1991–2006

Publications

Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics

Michael J. Pucci, Joanne J. Bronson, John F. Barrett et al. · Antimicrobial Agents and Chemotherapy · 2004 · 100 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +15

Discovery of the first antibacterial small molecule inhibitors of MurB

Joanne J. Bronson, Kenneth DenBleyker, Paul Falk et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 89 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid

Stan V. D'Andrea, Zhizhen Barbara Zheng, Kenneth DenBleyker et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 51 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials

Lawrence B. Snyder, Zhaoxing Meng, Robert Mate et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 43 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides

J Fung-Tomc, E Huczko, Terry M. Stickle et al. · Antimicrobial Agents and Chemotherapy · 1995 · 41 citations

Medicine, Infectious Diseases, Pharmacology +9

1–5 of 9